CTC
WST icon

Central Trust Company’s West Pharmaceutical WST Stock Holding History

Central Trust Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
+8
New +$2.45K ﹤0.01% 1376
2025
Q3 		– Sell
-7
Closed -$1.53K – 1532
2025
Q2 		$1.53K Hold
7
– – ﹤0.01% 1343
2025
Q1 		$1.57K Sell
7
-3
-30% -$827 ﹤0.01% 1345
2024
Q4 		$3.28K Sell
10
-18
-64% -$5.67K ﹤0.01% 1259
2024
Q3 		$8.4K Sell
28
-2
-7% -$612 ﹤0.01% 1092
2024
Q2 		$9.88K Sell
30
-61
-67% -$21.6K ﹤0.01% 1073
2024
Q1 		$36K Sell
91
-72
-44% -$26.6K ﹤0.01% 868
2023
Q4 		$57.4K Hold
163
– – ﹤0.01% 768
2023
Q3 		$61.2K Sell
163
-46
-22% -$17.8K ﹤0.01% 737
2023
Q2 		$79.9K Buy
209
+103
+97% +$36.8K ﹤0.01% 703
2023
Q1 		$36.7K Sell
106
-68
-39% -$19.9K ﹤0.01% 837
2022
Q4 		$41K Sell
174
-826
-83% -$196K ﹤0.01% 804
2022
Q3 		$246K Sell
1,000
-477
-32% -$145K 0.01% 489
2022
Q2 		$447K Sell
1,477
-1,007
-41% -$328K 0.01% 395
2022
Q1 		$1.02M Sell
2,484
-152
-6% -$59.5K 0.03% 314
2021
Q4 		$1.24M Buy
2,636
+531
+25% +$229K 0.03% 304
2021
Q3 		$894K Buy
2,105
+56
+3% +$23.6K 0.03% 330
2021
Q2 		$736K Buy
2,049
+1,694
+477% +$560K 0.03% 356
2021
Q1 		$100K Buy
+355
New +$102K ﹤0.01% 603

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Central Trust Company's WST Position: Q2 2026 in Review

Central Trust Company opened a new position in West Pharmaceutical (WST) in Q2 2026: 8 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings. This is a return to the name: Central Trust Company previously reported a position in WST as recently as Q2 2025.

Central Trust Company first reported a position in WST in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.24M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Central Trust Company held 8 shares of West Pharmaceutical worth $2.87K as of Q2 2026.
  • West Pharmaceutical was a new Central Trust Company position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1376 holding.
  • Central Trust Company first reported a position in West Pharmaceutical in Q1 2021 and has held it in 19 quarters since.
  • Central Trust Company's West Pharmaceutical position peaked at $1.24M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.